Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Farnaby

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Methods in Enzymology|February 10, 2023
Crystallization of VHL-based PROTAC-induced ternary complexesAndre J Wijaya, William Farnaby, Alessio Ciulli
Chemical Communications (Cambridge, England)|November 4, 2017
Modular synthesis of thirty lead-like scaffolds suitable for CNS drug discoveryJoan Mayol-Llinàs, William Farnaby, Adam Nelson
Current Opinion in Pharmacology|April 2, 2021
Transforming targeted cancer therapy with PROTACs: A forward-looking perspectiveWilliam Farnaby, Manfred Koegl, Darryl B McConnell, et al.
Drug Discovery Today|January 24, 2017
Assessing molecular scaffolds for CNS drug discoveryJoan Mayol-Llinàs, Adam Nelson, William Farnaby, et al.
Current Opinion in Structural Biology|February 22, 2023
Breaking free from the crystal lattice: Structural biology in solution to study protein degradersKevin Haubrich, Valentina A Spiteri, William Farnaby, et al.
Organic Letters|April 22, 2010
Synthesis of (-)-(S,S)-clemastine by invertive N --> C aryl migration in a lithiated carbamateAnne M Fournier, Robert A Brown, William Farnaby, et al.
ACS Chemical Biology|February 6, 2019
SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation RateMichael J Roy, Sandra Winkler, Scott J Hughes, et al.
Journal of the American Chemical Society|March 12, 2009
N to C aryl migration in lithiated carbamates: alpha-arylation of benzylic alcoholsJonathan Clayden, William Farnaby, Damian M Grainger, et al.
Journal of Medicinal Chemistry|August 13, 2021
Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)Tatsuki Koike, Masato Yoshikawa, Haruhi Kamisaki Ando, et al.
European Journal of Pharmacology|May 29, 2018
Identification of compounds acting as negative allosteric modulators of the LPA<sub>1</sub> receptorJonathan Ellery, Louise Dickson, Toni Cheung, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Methods in Enzymology|February 10, 2023
Crystallization of VHL-based PROTAC-induced ternary complexesAndre J Wijaya, William Farnaby, Alessio Ciulli
Chemical Communications (Cambridge, England)|November 4, 2017
Modular synthesis of thirty lead-like scaffolds suitable for CNS drug discoveryJoan Mayol-Llinàs, William Farnaby, Adam Nelson
Current Opinion in Pharmacology|April 2, 2021
Transforming targeted cancer therapy with PROTACs: A forward-looking perspectiveWilliam Farnaby, Manfred Koegl, Darryl B McConnell, et al.
Drug Discovery Today|January 24, 2017
Assessing molecular scaffolds for CNS drug discoveryJoan Mayol-Llinàs, Adam Nelson, William Farnaby, et al.
Current Opinion in Structural Biology|February 22, 2023
Breaking free from the crystal lattice: Structural biology in solution to study protein degradersKevin Haubrich, Valentina A Spiteri, William Farnaby, et al.
Organic Letters|April 22, 2010
Synthesis of (-)-(S,S)-clemastine by invertive N --> C aryl migration in a lithiated carbamateAnne M Fournier, Robert A Brown, William Farnaby, et al.
ACS Chemical Biology|February 6, 2019
SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation RateMichael J Roy, Sandra Winkler, Scott J Hughes, et al.
Journal of the American Chemical Society|March 12, 2009
N to C aryl migration in lithiated carbamates: alpha-arylation of benzylic alcoholsJonathan Clayden, William Farnaby, Damian M Grainger, et al.
Journal of Medicinal Chemistry|August 13, 2021
Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)Tatsuki Koike, Masato Yoshikawa, Haruhi Kamisaki Ando, et al.
European Journal of Pharmacology|May 29, 2018
Identification of compounds acting as negative allosteric modulators of the LPA<sub>1</sub> receptorJonathan Ellery, Louise Dickson, Toni Cheung, et al.
Pageof 3